A new method for developing stem cells enables the production of liver and pancreatic cells in “clinically relevant” quantities for the first time, paving the way for regenerative therapies.
Cambridge team which developed method to generate liver cells from skin cells has formed a new company to supply stem cell products to the drug discovery and regenerative medicine sectors.
Much hyped by the media, stem cells have tremendous power to improve human health. As part of the Cambridge Stem Cell Initiative, Dr Ludovic Vallier’s research in the Anne McLaren Laboratory for Regenerative Medicine shows how stem cells can further our understanding of disease and help deliver much-needed new treatments.
Cambridge research that created liver cells from stem cells has today been recognised with a national prize by the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs).
Cohesion, collaboration and clinical impact are the watchwords of a new phase of stem cell research in Cambridge.
<p>Research paves way for new liver disease research and possibly cell-based therapy.<br /> &nbsp;
© 2024 University of Cambridge